跳至主要内容
临床试验/ITMCTR2100004412
ITMCTR2100004412招募中1 期

Research on the Intervention of Virtual Reality Technology Based on TCM Syndrome Differentiation on Cardiovascular Severe Diseases

The Second Affiliated Hospital of Zhejiang Chinese Medical University0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
40 至 80(—)
性别
All

入选标准

  • 1. Patients with severe cardiovascular diseases (mainly including acute heart failure, unstable angina pectoris, acute non ST segment elevation myocardial infarction and hypertension subacute) in our hospital from October 2020 to January 2021;
  • 2. Patients aged 40-80 years;
  • 3. Patients receiving VR treatment within 48 hours after admission.

排除标准

  • 1. Patients with cardiogenic shock;
  • 2. Patients with malignant arrhythmia;
  • 3. Patients with acute ST segment elevation myocardial infarction.

研究者

发起方
The Second Affiliated Hospital of Zhejiang Chinese Medical University

相似试验